244 related articles for article (PubMed ID: 25783213)
21. [Not Available].
Menter T; Tzankov A; Dirnhofer S
Ther Umsch; 2017 Sep; 74(4):197-203. PubMed ID: 28950777
[No Abstract] [Full Text] [Related]
22. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers in melanoma.
Griewank KG
Scand J Clin Lab Invest Suppl; 2016; 245():S104-12. PubMed ID: 27467728
[TBL] [Abstract][Full Text] [Related]
24. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
Newcomer K; Robbins KJ; Perone J; Hinojosa FL; Chen D; Jones S; Kaufman CK; Weiser R; Fields RC; Tyler DS
Curr Probl Surg; 2022 Jan; 59(1):101030. PubMed ID: 35033317
[No Abstract] [Full Text] [Related]
25. [Molecular classification and markers of malignant melanoma].
Tímár J; Hársing J; Somlai B
Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathology diagnostics in cutaneous mesenchymal tumors.
Kutzner H; Requena L; Palmedo G; Mentzel T
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():36-49. PubMed ID: 23721641
[No Abstract] [Full Text] [Related]
27. Contemporary and potential future molecular diagnosis of melanoma.
Gandolfi G; Dallaglio K; Longo C; Moscarella E; Lallas A; Alfano R; Argenziano G; Ciarrocchi A
Expert Rev Mol Diagn; 2016 Sep; 16(9):975-85. PubMed ID: 27348706
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic and predictive markers of malignant melanoma].
Rásó E; Barbai T; Gyõrffy B; Tímár J
Magy Onkol; 2013 Jun; 57(2):79-83. PubMed ID: 23795352
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
[TBL] [Abstract][Full Text] [Related]
30. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
31. Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).
Visser M; van der Stoep N; Gruis N
Fam Cancer; 2019 Apr; 18(2):267-271. PubMed ID: 30659395
[No Abstract] [Full Text] [Related]
32. BRAF V600E mutation-specific antibody: A review.
Ritterhouse LL; Barletta JA
Semin Diagn Pathol; 2015 Sep; 32(5):400-8. PubMed ID: 25744437
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
34. Molecular Profiling in Cutaneous Melanoma.
Ji AL; Bichakjian CK; Swetter SM
J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
[TBL] [Abstract][Full Text] [Related]
35. Clinical germline genetic testing for melanoma.
Hansen CB; Wadge LM; Lowstuter K; Boucher K; Leachman SA
Lancet Oncol; 2004 May; 5(5):314-9. PubMed ID: 15120668
[TBL] [Abstract][Full Text] [Related]
36. Molecular testing in malignant melanoma.
Grossmann AH; Grossmann KF; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
[TBL] [Abstract][Full Text] [Related]
37. Dermoscopy in the era of dermato-oncology: from bed to bench side and retour.
Woltsche N; Schwab C; Deinlein T; Hofmann-Wellenhof R; Zalaudek I
Expert Rev Anticancer Ther; 2016 May; 16(5):531-41. PubMed ID: 26999650
[TBL] [Abstract][Full Text] [Related]
38. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
39. Technological advances for the detection of melanoma: Advances in molecular techniques.
Fried L; Tan A; Bajaj S; Liebman TN; Polsky D; Stein JA
J Am Acad Dermatol; 2020 Oct; 83(4):996-1004. PubMed ID: 32360759
[TBL] [Abstract][Full Text] [Related]
40. A novel SVM-ID3 hybrid feature selection method to build a disease model for melanoma using integrated genotyping and phenotype data from dbGaP.
Son YA; Yücebaş SC
Stud Health Technol Inform; 2014; 205():501-5. PubMed ID: 25160235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]